In the absence of federal action, states have attempted to rein in high pharmaceutical pricing by enacting laws aimed at regulating drug pricing. Following what now has become a trend, on March 13, 2018, Oregon became the newest state to
Recent effort to regulate pharmaceutical pricing deemed unconstitutional by Fourth Circuit
